ANTI-TUMOR NECROSIS FACTOR-α HUMANIZED ANTIBODY

PROBLEM TO BE SOLVED: To provide an anti-tumor necrosis factor humanized monoclonal antibody; a nucleic acid sequence encoding this; a vector comprising the nucleic acid sequence; and a host cell thereof; and to provide a pharmaceutical composition comprising the humanized antibody and a use of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HU ZHENXIANG, ZHANG JINGWEI, LI CHIANG, SUN LEE-HWEI KING, LIOU RUEY SHYAN, TAO DESHENG, BILL NAIAU SUN, SUN CECILY ROU-YUN, CHU BAOGUO, PENG YUCAI
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HU ZHENXIANG
ZHANG JINGWEI
LI CHIANG
SUN LEE-HWEI KING
LIOU RUEY SHYAN
TAO DESHENG
BILL NAIAU SUN
SUN CECILY ROU-YUN
CHU BAOGUO
PENG YUCAI
description PROBLEM TO BE SOLVED: To provide an anti-tumor necrosis factor humanized monoclonal antibody; a nucleic acid sequence encoding this; a vector comprising the nucleic acid sequence; and a host cell thereof; and to provide a pharmaceutical composition comprising the humanized antibody and a use of the pharmaceutical composition in preparing a medicament to diagnose and treat hTNFα-related diseases.SOLUTION: The invention provides an anti-tumor necrosis factor humanized monoclonal antibody comprising a heavy chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it; and a light chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it. 【課題】抗腫瘍壊死因子ヒト化モノクローナル抗体、これをコードする核酸配列、前記核酸配列を含むベクター及びその宿主細胞の提供。又、該ヒト化抗体を含む医薬組成物及びhTNFα関連疾患の診断と治療のための医薬の製造における前記医薬組成物の用途の提供。【解決手段】特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する重鎖と、特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する軽鎖と、を含む抗腫瘍壊死因子ヒト化モノクローナル抗体。【選択図】なし
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2016006052A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2016006052A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2016006052A3</originalsourceid><addsrcrecordid>eNrjZDBw9Avx1A0J9fUPUvBzdQ7yD_YMVnBzdA7xD9I9t1HBI9TX0c8zytVFAaTOyd8lkoeBNS0xpziVF0pzMyi5uYY4e-imFuTHpxYXJCan5qWWxHsFGBkYmhkYmBmYGjkaE6UIAO5vJ7c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-TUMOR NECROSIS FACTOR-α HUMANIZED ANTIBODY</title><source>esp@cenet</source><creator>HU ZHENXIANG ; ZHANG JINGWEI ; LI CHIANG ; SUN LEE-HWEI KING ; LIOU RUEY SHYAN ; TAO DESHENG ; BILL NAIAU SUN ; SUN CECILY ROU-YUN ; CHU BAOGUO ; PENG YUCAI</creator><creatorcontrib>HU ZHENXIANG ; ZHANG JINGWEI ; LI CHIANG ; SUN LEE-HWEI KING ; LIOU RUEY SHYAN ; TAO DESHENG ; BILL NAIAU SUN ; SUN CECILY ROU-YUN ; CHU BAOGUO ; PENG YUCAI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide an anti-tumor necrosis factor humanized monoclonal antibody; a nucleic acid sequence encoding this; a vector comprising the nucleic acid sequence; and a host cell thereof; and to provide a pharmaceutical composition comprising the humanized antibody and a use of the pharmaceutical composition in preparing a medicament to diagnose and treat hTNFα-related diseases.SOLUTION: The invention provides an anti-tumor necrosis factor humanized monoclonal antibody comprising a heavy chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it; and a light chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it. 【課題】抗腫瘍壊死因子ヒト化モノクローナル抗体、これをコードする核酸配列、前記核酸配列を含むベクター及びその宿主細胞の提供。又、該ヒト化抗体を含む医薬組成物及びhTNFα関連疾患の診断と治療のための医薬の製造における前記医薬組成物の用途の提供。【解決手段】特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する重鎖と、特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する軽鎖と、を含む抗腫瘍壊死因子ヒト化モノクローナル抗体。【選択図】なし</description><language>eng ; jpn</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160114&amp;DB=EPODOC&amp;CC=JP&amp;NR=2016006052A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160114&amp;DB=EPODOC&amp;CC=JP&amp;NR=2016006052A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HU ZHENXIANG</creatorcontrib><creatorcontrib>ZHANG JINGWEI</creatorcontrib><creatorcontrib>LI CHIANG</creatorcontrib><creatorcontrib>SUN LEE-HWEI KING</creatorcontrib><creatorcontrib>LIOU RUEY SHYAN</creatorcontrib><creatorcontrib>TAO DESHENG</creatorcontrib><creatorcontrib>BILL NAIAU SUN</creatorcontrib><creatorcontrib>SUN CECILY ROU-YUN</creatorcontrib><creatorcontrib>CHU BAOGUO</creatorcontrib><creatorcontrib>PENG YUCAI</creatorcontrib><title>ANTI-TUMOR NECROSIS FACTOR-α HUMANIZED ANTIBODY</title><description>PROBLEM TO BE SOLVED: To provide an anti-tumor necrosis factor humanized monoclonal antibody; a nucleic acid sequence encoding this; a vector comprising the nucleic acid sequence; and a host cell thereof; and to provide a pharmaceutical composition comprising the humanized antibody and a use of the pharmaceutical composition in preparing a medicament to diagnose and treat hTNFα-related diseases.SOLUTION: The invention provides an anti-tumor necrosis factor humanized monoclonal antibody comprising a heavy chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it; and a light chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it. 【課題】抗腫瘍壊死因子ヒト化モノクローナル抗体、これをコードする核酸配列、前記核酸配列を含むベクター及びその宿主細胞の提供。又、該ヒト化抗体を含む医薬組成物及びhTNFα関連疾患の診断と治療のための医薬の製造における前記医薬組成物の用途の提供。【解決手段】特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する重鎖と、特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する軽鎖と、を含む抗腫瘍壊死因子ヒト化モノクローナル抗体。【選択図】なし</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9Avx1A0J9fUPUvBzdQ7yD_YMVnBzdA7xD9I9t1HBI9TX0c8zytVFAaTOyd8lkoeBNS0xpziVF0pzMyi5uYY4e-imFuTHpxYXJCan5qWWxHsFGBkYmhkYmBmYGjkaE6UIAO5vJ7c</recordid><startdate>20160114</startdate><enddate>20160114</enddate><creator>HU ZHENXIANG</creator><creator>ZHANG JINGWEI</creator><creator>LI CHIANG</creator><creator>SUN LEE-HWEI KING</creator><creator>LIOU RUEY SHYAN</creator><creator>TAO DESHENG</creator><creator>BILL NAIAU SUN</creator><creator>SUN CECILY ROU-YUN</creator><creator>CHU BAOGUO</creator><creator>PENG YUCAI</creator><scope>EVB</scope></search><sort><creationdate>20160114</creationdate><title>ANTI-TUMOR NECROSIS FACTOR-α HUMANIZED ANTIBODY</title><author>HU ZHENXIANG ; ZHANG JINGWEI ; LI CHIANG ; SUN LEE-HWEI KING ; LIOU RUEY SHYAN ; TAO DESHENG ; BILL NAIAU SUN ; SUN CECILY ROU-YUN ; CHU BAOGUO ; PENG YUCAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2016006052A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>HU ZHENXIANG</creatorcontrib><creatorcontrib>ZHANG JINGWEI</creatorcontrib><creatorcontrib>LI CHIANG</creatorcontrib><creatorcontrib>SUN LEE-HWEI KING</creatorcontrib><creatorcontrib>LIOU RUEY SHYAN</creatorcontrib><creatorcontrib>TAO DESHENG</creatorcontrib><creatorcontrib>BILL NAIAU SUN</creatorcontrib><creatorcontrib>SUN CECILY ROU-YUN</creatorcontrib><creatorcontrib>CHU BAOGUO</creatorcontrib><creatorcontrib>PENG YUCAI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HU ZHENXIANG</au><au>ZHANG JINGWEI</au><au>LI CHIANG</au><au>SUN LEE-HWEI KING</au><au>LIOU RUEY SHYAN</au><au>TAO DESHENG</au><au>BILL NAIAU SUN</au><au>SUN CECILY ROU-YUN</au><au>CHU BAOGUO</au><au>PENG YUCAI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-TUMOR NECROSIS FACTOR-α HUMANIZED ANTIBODY</title><date>2016-01-14</date><risdate>2016</risdate><abstract>PROBLEM TO BE SOLVED: To provide an anti-tumor necrosis factor humanized monoclonal antibody; a nucleic acid sequence encoding this; a vector comprising the nucleic acid sequence; and a host cell thereof; and to provide a pharmaceutical composition comprising the humanized antibody and a use of the pharmaceutical composition in preparing a medicament to diagnose and treat hTNFα-related diseases.SOLUTION: The invention provides an anti-tumor necrosis factor humanized monoclonal antibody comprising a heavy chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it; and a light chain having a specific amino acid sequence or an amino acid sequence maintaining at least 75% homologous to it. 【課題】抗腫瘍壊死因子ヒト化モノクローナル抗体、これをコードする核酸配列、前記核酸配列を含むベクター及びその宿主細胞の提供。又、該ヒト化抗体を含む医薬組成物及びhTNFα関連疾患の診断と治療のための医薬の製造における前記医薬組成物の用途の提供。【解決手段】特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する重鎖と、特定のアミノ酸配列またはそれに対し少なくとも75%の相同性を保持するアミノ酸配列を有する軽鎖と、を含む抗腫瘍壊死因子ヒト化モノクローナル抗体。【選択図】なし</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2016006052A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title ANTI-TUMOR NECROSIS FACTOR-α HUMANIZED ANTIBODY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T17%3A01%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HU%20ZHENXIANG&rft.date=2016-01-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2016006052A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true